Authors:
Wolff, RA
Evans, DB
Gravel, DM
Lenzi, R
Pisters, PWT
Lee, JE
Janjan, NA
Charnsangavej, C
Abbruzzese, JL
Citation: Ra. Wolff et al., Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma, CLIN CANC R, 7(8), 2001, pp. 2246-2253
Authors:
Wen, XX
Wu, QP
Lu, Y
Fan, Z
Charnsangavej, C
Wallace, S
Chow, D
Li, C
Citation: Xx. Wen et al., Poly(ethylene glycol)-conjugated anti-EGF receptor antibody C225 with radiometal chelator attached to the termini of polymer chains, BIOCONJ CHE, 12(4), 2001, pp. 545-553
Authors:
Choi, H
Whitman, G
Ro, J
Charnsangavej, C
Citation: H. Choi et al., Radiologic-pathologic conferences of the University of Texas M. D. Anderson Cancer Center - Benign schwannoma in the porta hepatis, AM J ROENTG, 177(3), 2001, pp. 652-652
Authors:
Choi, H
Loyer, EM
DuBrow, RA
Kaur, H
David, CL
Huang, S
Curley, S
Charnsangavej, C
Citation: H. Choi et al., Radio-frequency ablation of liver tumors: Assessment of therapeutic response and complications, RADIOGRAPHI, 21, 2001, pp. S41-S54
Authors:
Crane, CH
Janjan, NA
Evans, DB
Wolff, RA
Ballo, MT
Milas, L
Mason, K
Charnsangavej, C
Pisters, PWT
Lee, JE
Lenzi, R
Vauthey, JN
Wong, A
Phan, T
Nguyen, Q
Abbruzzese, JL
Citation: Ch. Crane et al., Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer, INT J PANCR, 29(1), 2001, pp. 9-18
Authors:
Wen, XX
Wu, QP
Ke, S
Ellis, L
Charnsangavej, C
Delpassand, AS
Wallace, S
Li, C
Citation: Xx. Wen et al., Conjugation with In-111-DTPA-poly(Ethylene glycol) improves imaging of Anti-EGF receptor antibody C225, J NUCL MED, 42(10), 2001, pp. 1530-1537
Authors:
Crane, CH
Wolff, RA
Abbruzzese, JL
Evans, DB
Milas, L
Mason, K
Charnsangavej, C
Pisters, PWT
Lee, JE
Lenzi, R
Lahoti, S
Vauthey, JN
Janjan, NA
Citation: Ch. Crane et al., Combining gemcitabine with radiation in pancreatic cancer: Understanding important variables influencing the therapeutic index, SEMIN ONCOL, 28(3), 2001, pp. 25-33
Authors:
Li, C
Ke, S
Wu, QP
Tansey, W
Hunter, N
Buchmiller, LM
Milas, L
Charnsangavej, C
Wallace, S
Citation: C. Li et al., Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy, CLIN CANC R, 6(7), 2000, pp. 2829-2834
Authors:
Li, C
Ke, S
Wu, QP
Tansey, W
Hunter, N
Buchmiller, LM
Milas, L
Charnsangavej, C
Wallace, S
Citation: C. Li et al., Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate, INT J RAD O, 48(4), 2000, pp. 1119-1126
Authors:
Li, C
Newman, RA
Wu, QP
Ke, S
Chen, W
Hutto, T
Kan, ZX
Brannan, MD
Charnsangavej, C
Wallace, S
Citation: C. Li et al., Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor, CANC CHEMOT, 46(5), 2000, pp. 416-422
Authors:
Vauthey, JN
Chaoui, A
Do, KA
Bilimoria, MM
Fenstermacher, MJ
Charnsangavej, C
Hicks, M
Alsfasser, G
Lauwers, G
Hawkins, IF
Caridi, J
Citation: Jn. Vauthey et al., Standardized measurement of the future liver remnant prior to extended liver resection: Methodology and clinical associations, SURGERY, 127(5), 2000, pp. 512-519
Authors:
Bold, RJ
Charnsangavej, C
Cleary, KR
Jennings, M
Madary, A
Leach, SD
Abbruzzese, JL
Pisters, PWT
Lee, JE
Evans, DB
Citation: Rj. Bold et al., Major vascular resection as part of pancreaticoduodenectomy for cancer: Radiologic, intraoperative, and pathologic analysis, J GASTRO S, 3(3), 1999, pp. 233-243
Authors:
Li, C
Price, JE
Milas, L
Hunter, NR
Ke, S
Yu, DF
Charnsangavej, C
Wallace, S
Citation: C. Li et al., Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors, CLIN CANC R, 5(4), 1999, pp. 891-897
Authors:
Ng, CS
Loyer, EM
Iyer, RB
David, CL
DuBrow, RA
Charnsangavej, C
Citation: Cs. Ng et al., Metastases to the pancreas from renal cell carcinoma: Findings on three-phase contrast-enhanced helical CT, AM J ROENTG, 172(6), 1999, pp. 1555-1559
Authors:
Patt, YZ
Hoque, A
Roh, M
Ellis, L
Lozano, R
Carrasco, CH
Charnsangavej, C
Cleary, K
Citation: Yz. Patt et al., Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon alpha 2B, doxorubicin, and 5-fluorouracil - A communication, AM J CL ONC, 22(2), 1999, pp. 209-213